Pharmacodynamics of vancomycin and ampicillin alone and in combination with gentamicin once daily or thrice daily against Enterococcus faecalis in an in vitro infection model

Journal of Antimicrobial Chemotherapy

Volumn 46, Issue 1, 2000, Pages 79-86

  Houlihan, Heather H ^a   Stokes, Daniela P ^b   Rybak, Michael J ^a,b  

^a Detroit Rec Hosp/Univ Hlth C   (Canada)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMPICILLIN; GENTAMICIN; VANCOMYCIN;

ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; BACTERIUM COLONY; CONTROLLED STUDY; DENSITY; ENDOCARDITIS; ENTEROCOCCUS FAECALIS; FIBRIN CLOT; GROWTH REGULATION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; NONBIOLOGICAL MODEL; NONHUMAN; PHARMACODYNAMICS; SIMULATION; THROMBOCYTE AGGREGATION; DRUG ADMINISTRATION; DRUG COMBINATION; DRUG EFFECT; MICROBIOLOGICAL EXAMINATION;

AMPICILLIN; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ENTEROCOCCUS FAECALIS; GENTAMICINS; HUMANS; MICROBIAL SENSITIVITY TESTS; VANCOMYCIN;

EID: 0033940956     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/46.1.79     Document Type: Article

References (34)

1. Eliopoulos, G. M. (1992). Enterococcal endocarditis. In Infective Endocarditis, 2nd edn, (Kaye, D., Ed.), pp. 209-23. Raven Press, New York.
2. Lewis, C. M. & Zervos, M. J. (1990). Clinical manifestations of enterococcal infection. European Journal of Clinical Microbiology and Infectious Diseases 9, 111-7.
3. Maki, D. G. & Agger, W. A. (1988). Enterococcal bacteremia: clinical features, the risk of endocarditis, and management. Medicine 67, 248-69.
4. Megran, D. W. (1992). Enterococcal endocarditis. Clinical Infectious Diseases 15, 63-71.
5. Murray, B. E. (1990). The life and times of Enterococcus. Clinical Microbiology Reviews 3, 46-65.
6. Jawetz, E., Gunnuson, J. B. & Coleman, V. R. (1950). The combined action of penicillin plus streptomycin or chloromycetin on enterococci in vitro. Science 111, 254-6.
7. 14C-labeled streptomycin by enterococci. Journal of Clinical Investigation 50, 2580-4.
8. Moellering, R. C., Wennersten, C. & Weinberg, A. N. (1971). Studies on antibiotic synergism against enterococci. I. Bacteriologic studies. Journal of Laboratory and Clinical Medicine 77, 821-8.
9. Robbins, W. C. & Thompsett, R. (1951). Treatment of enterococcal endocarditis and bacteremia. Results of combined therapy with penicillin and streptomycin. American Journal of Medicine 10, 278-99.
10. Eliopoulos, G. M. & Moellering, R. C. (1991). Antimicrobial combinations. In Antibiotics in Laboratory Medicine, 3rd edn, (Lorian, V., Ed.), pp. 432-92. Williams & Wilkins, Baltimore, MD.
11. Wilson, W. R., Karchmer, A. W., Dajani, A. S., Taubert, K. A., Bayer, A., Kaye, D. et al. (1995). Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci and HACEK microorganisms. American Heart Association. Journal of the American Medical Association 274, 1706-13.
12. Ali, M. Z. & Goetz, M. B. (1997). A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides. Clinical Infectious Diseases 24, 796-809.
13. Gilbert, D. N. (1991). Once-daily aminoglycoside therapy. Antimicrobial Agents and Chemotherapy 35, 399-405.
14. Gilbert, D. N. (1997). Meta-analyses are no longer required for determining the efficacy of single daily dosing of aminoglycosides. Clinical Infectious Diseases 24, 816-9.
15. Hatala, R., Dinh, T. & Cook, D. J. (1996). Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis. Annals of Internal Medicine 124, 717-25.
16. Blatter, M., Fluckiger, U., Entenza, J., Glauser, M. P. & Francioli, P. (1993). Simulated human serum profiles of one daily dose of ceftriaxone plus netilmicin in treatment of experimental streptococcal endocarditis. Antimicrobial Agents and Chemotherapy 37, 1971-6.
17. Clewell, D. B. (1981). Plasmids, drug resistance and gene transfer in the genus Streptococcus. Microbiological Reviews 45, 409-36
18. Cremieux, A. C. & Carbon, C. (1992). Pharmacokinetic and pharmacodynamic requirements of antibiotic therapy of experimental endocarditis. Antimicrobial Agents and Chemotherapy 36, 2069-74.
19. Fantin, B. & Carbon, C. (1990). Importance of the aminoglycoside dosing regimen in the penicillin-netilmicin combination for the treatment of Enterococcus faecalis-induced experimental endocarditis. Antimicrobial Agents and Chemotherapy 34, 2387-91.
20. Francioli, P. B. & Glauser, M. P. (1993). Synergistic activity of ceftriaxone combined with netilmicin administered once-daily for the treatment of experimental streptococcal endocarditis. Antimicrobial Agents and Chemotherapy 37, 207-12.
21. Francioli, P. B., Ruch, W. & Stambulin, D. (1995). Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone and netilmicin for 14 days: a prospective multicenter study. Clinical Infectious Diseases 21, 1406-10.
22. Gavalda, J., Cardona, P. J., Almirante, B., Capdevila, J. A., Laguarda, M., Pou, L. et al. (1996). Treatment of experimental endocarditis due to Enterococcus faecalis using once-daily dosing regimen of gentamicin plus simulated profiles of ampicillin in human serum. Antimicrobial Agents and Chemotherapy 40, 173-8.
23. Gavalda, J., Pahissa, A., Almirante, B., Laguarda, M., Crespo, E., Pou, L. et al. (1995). Effect of gentamicin dosing interval on therapy of viridans streptococcal experimental endocarditis with gentamicin plus penicillin. Antimicrobial Agents and Chemotherapy 39, 2098-103
24. Schwank, S. & Blaser, J. (1996). Once- versus thrice-daily netilmicin combined with amoxicillin, penicillin, or vancomycin against Enterococcus faecalis in a pharmacodynamic in vitro model. Antimicrobial Agents and Chemotherapy 40, 2258-61.
25. Korzeniowski, O. & Sande, M. A. (1982). Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: a prospective study. Annals of Internal Medicine 97, 496-503
26. Chambers, H. F., Miller, R. T. & Newman, M. D. (1988). Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy. Annals of Internal Medicine 109, 619-24.
27. National Committee for Clinical Laboratory Standards. (1997). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Fourth Edition. Approved Standard M7-A4. NCCLS, Villanova, PA.
28. Thompson, D. F., Letassy, N. A. & Thompson, G. D. (1988). Fibrin glue: a review of its preparation, efficacy, and adverse effects as topical hemostat. Drug Intelligence and Clinical Pharmacy 22, 946-52.
29. Kang, S. L. & Rybak, M. J. (1995). Pharmacodynamics of RP 59500 alone and in a combination with vancomycin against Staphylococcus aureus in an in vitro-infected fibrin clot model. Antimicrobial Agents and Chemotherapy 39, 1505-11.
30. McGrath, B. J., Kang, S. L., Kaatz, G. W. & Rybak, M. J. (1994). Bacterial activities of teicoplanin, vancomycin, and gentamicin bactericidal activity alone and in combination against Staphylococcus aureus in an in vitro pharmacodynamic model of endocarditis. Antimicrobial Agents and Chemotherapy 38, 2034-40.
31. Blaser, J. (1985). In-vitro model for simultaneous simulation of the serum kinetics of two drugs with different half-lives. Journal of Antimicrobial Chemotherapy 15, Suppl. A, 125-30.
32. Hessen, M. T., Pitsakis, P. G. & Levison, M. E. (1988). Absence of a postantibiotic effect in experimental Pseudomonas endocarditis treated with imipenem, with or without gentamicin. Journal of Infectious Diseases 158, 542-8.
33. Hessen, M. T., Pistakis, P. G. & Levison, M. E. (1989). Postantibiotic effect of penicillin plus gentamicin versus Enterococcus faecalis in vitro and in vivo. Antimicrobial Agents and Chemotherapy 33, 608-11.
34. Perdikaris, G., Giamarellou, H., Pefanis, A., Donta, I. & Karayiannakos, P. (1995). Vancomycin or vancomycin plus netilmicin for methicillin- and gentamicin-resistant Staphylococcus aureus aortic valve experimental endocarditis. Antimicrobial Agents and Chemotherapy 39, 2289-94.